文献速递甲状腺疾病

热消融技术治疗原发性甲状腺微小乳头状癌的疗效与安全性:系统评价与Meta分析

Efficacy and Safety of Thermal Ablation Techniques for the Treatment of Primary Papillary Thyroid Microcarcinoma: A Systematic Review and Meta-Analysis.
PubMed 文献 · Thyroid · 2020-02-04

该系统评价与Meta分析检索Pubmed MEDLINE和EMBASE数据库至2019年8月10日,纳入11篇文献共715例患者,评估射频消融、激光消融和微波消融治疗原发性甲状腺微小乳头状癌的疗效与安全性。完全消失和复发合并比例分别为57.6%和0.4%,总体和主要并发症合并比例分别为3.2%和0.7%。各消融方式在完全消失方面存在显著异质性,激光消融在缩小体积方面效果低于射频消融和微波消融。

要点

  • 热消融治疗原发性甲状腺微小乳头状癌的完全消失合并比例为57.6%,复发合并比例为0.4%。
  • 总体并发症和主要并发症合并比例分别为3.2%和0.7%。
  • 激光消融缩小体积效果低于射频消融和微波消融,平均体积缩小率分别为88.6%、99.3%和95.3%。

核心结论

  • 所有热消融技术治疗原发性甲状腺微小乳头状癌均有效且安全,但每种方式在完全消失方面存在显著异质性,激光消融在缩小体积方面效果低于射频消融和微波消融。

研究设计与样本

  • 系统评价与Meta分析,检索Pubmed MEDLINE和EMBASE数据库至2019年8月10日,从105篇潜在文献中纳入11篇合格文献,共715例患者。

主要发现

  • 原发性甲状腺微小乳头状癌完全消失和复发的合并比例分别为57.6%[95%CI:35.4-79.8]和0.4%[95%CI:0-1.1]。
  • 平均体积缩小及其缩小率的合并估计分别为73.5 mm3[52.4-94.6 mm3]和98.1%[95%CI:96.7-99.5]。
  • 总体并发症和主要并发症的合并比例分别为3.2%[95%CI:1.1-5.2]和0.7%[95%CI:0-1.5]。
  • 完全消失(P < 0.001,I²=99%)、平均体积缩小(P < 0.001,I²=93%)及其缩小率(P < 0.001,I²=86%)均存在显著研究间异质性。
  • 亚组分析显示不同治疗方式间完全消失比例存在异质性(I²范围95-100%),射频消融平均体积缩小率最高为99.3%,微波消融为95.3%,激光消融为88.6%(P < 0.001)。

局限性

  • 完全消失、平均体积缩小及其缩小率均存在显著研究间异质性(P < 0.001,I²分别为99%、93%和86%)。
  • 亚组分析显示不同治疗方式间完全消失比例存在异质性(I²范围95-100%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: The increased incidence of primary papillary thyroid microcarcinoma (PTMC) has led to increased research in the field of nonsurgical therapeutic options for those who refuse surgery or are at high risk for surgery. The study aimed at comprehensively evaluating the efficacy and safety of thermal ablation techniques for the treatment of PTMC via a systematic review and meta-analysis. Methods: The Pubmed MEDLINE and EMBASE databases were searched for studies reporting the efficacy and safety of thermal ablations (radiofrequency-, laser-, and microwave-ablations [RFA, LA, and MWA]) until August 10, 2019. A review of 105 potential papers identified 11 eligible papers, including 715 patients. The pooled proportions of complete disappearance and recurrence, and the pooled estimates of mean volume reduction and its rate of the treated PTMC were assessed by using random-effects modeling. The pooled proportions of overall and major complications were calculated. Subgroup analysis was performed according to the treatment modality. Between-study heterogeneity was explored by using χ2 statistic for pooled estimates and inconsistency index I2. Quality of the studies was evaluated by using the Risk of Bias Assessment Tool for Nonrandomized Studies. Results: The pooled proportions of complete disappearance and recurrence of PTMC were 57.6% [95% confidence interval (CI): 35.4-79.8] and 0.4% [95% CI: 0-1.1], respectively. The pooled estimates of mean volume reduction and its rate were 73.5 mm3 [52.4-94.6 mm3] and 98.1% [95% CI: 96.7-99.5], respectively. The pooled proportions of overall and major complications were 3.2% [95% CI: 1.1-5.2] and 0.7% [95% CI: 0-1.5], respectively. Significant between-study heterogeneity was observed for complete disappearance (p < 0.001, I2: 99%), mean volume reduction (p < 0.001, I2: 93%), and its rate (p < 0.001, I2: 86%). Subgroup analysis revealed heterogeneity of the complete disappearance proportion among the treatment modality (I2 range: 95-100%). RFA showed the highest mean volume reduction rate (99.3%), followed by MWA (95.3%) and LA (88.6%) (p < 0.001). Conclusions: All thermal ablation techniques were effective and safe for the treatment of PTMC. However, each treatment modality had significant heterogeneity with respect to complete disappearance of PTMC. Compared with RFA and MWA, LA was less effective in reducing the volume of PTMC.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Choi Y, Jung SL. Efficacy and Safety of Thermal Ablation Techniques for the Treatment of Primary Papillary Thyroid Microcarcinoma: A Systematic Review and Meta-Analysis. Thyroid. 2020. PMID: 31801432. doi:10.1089/thy.2019.0707

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。